PolyXen 平台 :PolyXen是蛋白质和肽药物输送的使能平台技术。它使用生物聚合物聚唾液酸(PSA)来延长药物的半衰期,并可能提高治疗肽和蛋白质的稳定性。附着部位和PSA链的长度都可以通过改变分子的表观流体力学半径来影...查看全文
牛股小红书2022-04-28 13:48
$Xenetic Biosciences(XBIO)$ 与CLS Therapeutics签署了独家许可和再许可协议,以开发其基于DNA酶的介入性肿瘤学平台,旨在改善现有治疗,包括免疫疗法。
根据协议,Xenetic拥有CLS知识产权的独家许可证,用于在癌症中使用DNA酶,包括DNA酶与标准疗法(包括化疗、放疗和检查点抑制剂)的系统联...查看全文
$Xenetic Biosciences(XBIO)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001683168-22-003011 Act: 34 Size: 243 KB 网页链接
$Xenetic Biosciences(XBIO)$ 8-K Current report, items 1.01, 2.01, 3.02, 7.01, and 9.01 Accession Number: 0001683168-22-002961 Act: 34 Size: 299 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-22-002002 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-22-002000 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-22-002001 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-22-001853 Act: 34 Size: 279 KB 网页链接
$Xenetic Biosciences(XBIO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001683168-22-001839 Act: 34 Size: 6 MB 网页链接
$Xenetic Biosciences(XBIO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001683168-21-006669 Act: 33 Size: 89 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-21-006234 Size: 5 KB 网页链接
$Xenetic Biosciences(XBIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-21-006228 Size: 5 KB 网页链接